Personal devices in crisis? Risks vs. rewards of BYOD policies in pharmaceuticals
Pharmaceutical companies face a tough choice between enabling BYOD or issuing corporate devices. Understand the risks, rewards, and compliance factors of both.
Regulatory Wrap Episode 71: FDA takes aim at pharma companies’ social media activity
In Regulatory Wrap for the week to October 3, Ryan Thaxton explores the growing spotlight on pharma companies’ social media activity.
Pharma compliance solutions and regulatory success
The pharmaceutical industry operates under some of the strictest oversight in the business world, where a single misstep can cost millions and derail years of research. Consequently, robust pharma compliance solutions are fundamental to ensuring regulatory success and achieving operational efficiency.
FDA takes aim at pharmaceuticals’ social media activity
The FDA is turning its eye towards pharmaceuticals’ social media use. Review the laws and regulations triggering FDA warning letters and how to stay compliant.
Four key challenges for compliant mobile communications in healthcare and life sciences
Compliance teams in healthcare and life sciences must balance both regulatory restrictions and the needs of employees to achieve compliant mobile communications with corporate devices.
Managing the compliance risks of ephemeral messaging to meet DOJ guidance in healthcare and life sciences
Healthcare organizations and the pharmaceutical industry must look to implement solutions to ephemeral messaging in their compliance strategies.
Raising your Archiving IQ: Healthcare to take care
Does your organisation have all the tools it needs to properly preserve and capture all business communications?
6 tips to enhance eDiscovery practices for healthcare
Does your organization have sound eDiscovery processes in place? Receive tips you can employ in preparation for a potential investigation or audit.
